117 related articles for article (PubMed ID: 1322481)
41. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
[TBL] [Abstract][Full Text] [Related]
42. Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities.
Mor M; Silva C; Vacondio F; Plazzi PV; Bertoni S; Spadoni G; Diamantini G; Bedini A; Tarzia G; Zusso M; Franceschini D; Giusti P
J Pineal Res; 2004 Mar; 36(2):95-102. PubMed ID: 14962060
[TBL] [Abstract][Full Text] [Related]
43. Binding characteristics and regional distribution of [125I]iodomelatonin binding sites in the brain of the human fetus.
Yuan H; Lu Y; Pang SF
Neurosci Lett; 1991 Sep; 130(2):229-32. PubMed ID: 1686640
[TBL] [Abstract][Full Text] [Related]
44. The chick retinal melatonin receptor revisited: localization and modulation of agonist binding with guanine nucleotides.
Laitinen JT; Saavedra JM
Brain Res; 1990 Oct; 528(2):349-52. PubMed ID: 2176912
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
Nonno R; Lucini V; Pannacci M; Mazzucchelli C; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1998 Jun; 124(3):485-92. PubMed ID: 9647472
[TBL] [Abstract][Full Text] [Related]
46. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
[TBL] [Abstract][Full Text] [Related]
47. Pharmacology and function of melatonin receptors.
Dubocovich ML
FASEB J; 1988 Sep; 2(12):2765-73. PubMed ID: 2842214
[TBL] [Abstract][Full Text] [Related]
48. 2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides.
Nonno R; Lucini V; Stankov B; Fraschini F
Neurosci Lett; 1995 Jul; 194(1-2):113-6. PubMed ID: 7478190
[TBL] [Abstract][Full Text] [Related]
49. Effect of GABA on melatonin content in golden hamster retina.
Jaliffa CO; Faillace MP; Lacoste FF; Llomovatte DW; Keller Sarmiento MI; Rosenstein RE
J Neurochem; 1999 May; 72(5):1999-2005. PubMed ID: 10217277
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
51. Melatonin receptors.
Krause DN; Dubocovich ML
Annu Rev Pharmacol Toxicol; 1991; 31():549-68. PubMed ID: 1648339
[No Abstract] [Full Text] [Related]
52. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells.
Eison AS; Mullins UL
Life Sci; 1993; 53(24):PL393-8. PubMed ID: 8246675
[TBL] [Abstract][Full Text] [Related]
53. 2-[125I]Iodomelatonin binding sites in the quail heart: characteristics, distribution and modulation by guanine nucleotides and cations.
Pang CS; Tang PL; Song Y; Brown GM; Pang SF
Life Sci; 1996; 58(13):1047-57. PubMed ID: 8622557
[TBL] [Abstract][Full Text] [Related]
54. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites.
Molinari EJ; North PC; Dubocovich ML
Eur J Pharmacol; 1996 Apr; 301(1-3):159-68. PubMed ID: 8773460
[TBL] [Abstract][Full Text] [Related]
55. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
56. Circadian and photoperiodic time measurement in male Syrian hamsters following lesions of the melatonin-binding sites of the paraventricular thalamus.
Ebling FJ; Maywood ES; Humby T; Hastings MH
J Biol Rhythms; 1992; 7(3):241-54. PubMed ID: 1330085
[TBL] [Abstract][Full Text] [Related]
57. 2[125I]iodomelatonin binding sites in spleens of guinea pigs.
Poon AM; Pang SF
Life Sci; 1992; 50(22):1719-26. PubMed ID: 1316983
[TBL] [Abstract][Full Text] [Related]
58. Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases.
Suzuki N; Somei M; Seki A; Reiter RJ; Hattori A
J Pineal Res; 2008 Oct; 45(3):229-34. PubMed ID: 18691356
[TBL] [Abstract][Full Text] [Related]
59. GTP modulates [125I]iodomelatonin binding to a picomolar-affinity site in the Syrian hamster hypothalamus.
Niles LP
Eur J Pharmacol; 1990 Jul; 189(1):95-8. PubMed ID: 2226639
[TBL] [Abstract][Full Text] [Related]
60. 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate-solubilized binding sites for 2-[125I]iodomelatonin in chick brain retain sensitivity to guanine nucleotides.
Ying SW; Niles LP
J Neurochem; 1991 Feb; 56(2):580-6. PubMed ID: 1846401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
